Risk Of Developing Liver Cancer After HCV Treatment

▼
Showing posts with label zepatier(elbasvir and grazoprevir). Show all posts
Showing posts with label zepatier(elbasvir and grazoprevir). Show all posts
Thursday, July 26, 2018

EBR/GZR safe/effective for people with HCV receiving opioid agonist therapy

›
Clin Transl Sci. 2018 Jul 24. doi: 10.1111/cts.12564. [Epub ahead of print] No Pharmacokinetic Interactions Between Elbasvir or Grazop...
Friday, July 20, 2018

Merck To Steeply Cut Price of Hepatitis C Drug Zepatier

›
Merck To Steeply Cut Price of Hepatitis C Drug Zepatier July 20, 2018 The company announced that it plans to reduce other drugs in its por...
Monday, May 14, 2018

Elbasvir and grazoprevir with or without ribavirin, treatment–naive participants HCV genotype 2, 4, 5 or 6

›
Patients with non-genotype 1 HCV infection differ with regard to response to DAAs. This study evaluated the efficacy and safety of EBR/GZR, ...
Saturday, April 14, 2018

International Liver Congress 2018: 8-weeks of Zepatier (elbasvir/grazoprevir) may effectively treat HCV genotype 4

›
8-weeks of Zepatier may effectively treat HCV genotype 4 April 14, 2018 PARIS — In patients with hepatitis C virus genotype 4, 8 weeks of Z...
Wednesday, April 4, 2018

Elbasvir/grazoprevir in Asia‐Pacific/Russian participants with chronic hepatitis C genotype 1, 4, or 6 infection

›
Elbasvir/grazoprevir in Asia‐Pacific/Russian participants with chronic hepatitis C virus genotype 1, 4, or 6 infection Jacob George Eduard...
Saturday, March 17, 2018

Cost-effectiveness analysis of Zepatier treating HCV genotype 1 in stage 4-5 chronic kidney disease patients in France

›
Cost-effectiveness analysis of elbasvir-grazoprevir regimen for treating hepatitis C virus genotype 1 infection in stage 4-5 chronic kidney...
Saturday, October 21, 2017

The Liver Meeting® 2017 - ZEPATIER® High SVR In HCV Patients with Kidney disease

›
Real-World Study Shows ZEPATIER® (Elbasvir and Grazoprevir) Resulted in High Rates of Sustained Virologic Response in Patients with Chronic...
Tuesday, October 17, 2017

The changing HCV treatment cascade

›
Healio HCV Next Pharmacology Consult The changing HCV treatment cascade Infectious Disease News, October 2017 Jocelyn Mason, PharmD; K...
Monday, October 16, 2017

Merck targets high-risk military veterans for hepatitis C lessons

›
In case you missed it Press Release Merck Joins with the American Liver Foundation to Educate U.S. Veterans on Chronic Hepatitis C Vir...
Tuesday, October 3, 2017

Merck to Present New Data on ZEPATIER® (elbasvir and grazoprevir) at The Liver Meeting® 2017

›
Merck to Present New Data on ZEPATIER® (elbasvir and grazoprevir) for the Treatment of Chronic Hepatitis C Virus Infection at The Liver Meet...
Saturday, July 22, 2017

Hepatitis C Treatment Regimens Are Cost-Effective: But Compared With What?

›
Hepatitis C Treatment Regimens Are Cost-Effective: But Compared With What? T. Joseph Mattingly II, PharmD, MBA1, Julia F. Slejko, PhD1, and...
Monday, June 26, 2017

Swiss hepatitis C sufferers to get full access to expensive drug

›
Swiss hepatitis C sufferers to get full access to expensive drug By Anand Chandrasekhar The Federal Office of Public Health has announced ...
Saturday, May 27, 2017

May 2017 - Hepatitis C in a New Era: A Review of Current Therapies

›
P T. 2017;42(5) : 316-329 Hepatitis C in a New Era: A Review of Current Therapies Troy Kish PharmD, BCPS Andrew Aziz PharmD ...